A bone scan revealed widespread metastases and high resolution contrast computed tomography scan of the head demonstrated destruction of the pituitary fossa by a solitary enhancing mass eroding inferiorly into the sphenoid sinus and posteriorly through the dorsum sella to reach the pons. There was both supra and parasellar extension (Fig IA and B) .
A provisional diagnosis of pituitary apoplexy arising from infarction of a non-functioning adenoma was made. The patient's visual acuity deteriorated despite high dose dexamethasone and he underwent trans-sphenoidal resection of the tumour.
At operation a radical resection of the tumour was undertaken. The consistency of the tumour was haemorrhagic with evidence of old blood indicative of previous bleeds within the lesion. The diagnosis of pituitary apoplexy was confirmed. Postoperatively the patient made an uneventful recovery and underwent a course of fractionated radiotherapy. There was no improvement of his visual acuity or eye movements.
Histology showed that metastatic prostatic adenocarcinoma with extensive necrosis had completely replaced the normal pituitary architecture (Fig 2) .
Comment
The sudden swelling of a pituitary tumour due to ischaemic necrosis or infarct was first described as pituitary apoplexy by Brougham et al. ' The typical history is one of sudden severe headache and vomiting coupled with signs of meningism and visual loss or ophthalmoplegia.
Ophthalmoplegia is present in up to 6% of patients with pituitary adenoma. Patients with sella metastases commonly present with cDI whereas this occurs in under 2% of patients with a pituitary adenoma.? Although well described as a presenting sign ofpituitary apoplexy the occurrence of complete bilateral ophthalmoplegia resulting from pituitary apoplexy due to a prostatic metastasis has not been previously reported in English language publications.
Prostatic carcinoma classically metastasises to bone, lung, and liver3: brain metastases are seldom evident antemortem,4 particularly as a presenting feature.' Surveys of several large series of patients with prostatic carcinoma find the incidence of pituitary metastases to be between 1 and 6%.67 Several factors including the failure to examine pituitary tissue microscopically at post mortem8 and the high incidence of cerebral vascular events in this age group may, however, lead to underreporting.
The route of pituitary metastases involves several mechanisms. The paravertebral venous plexus draining the prostate gland has been proposed as the primary route for parenchymal brain metastases. 9 
